Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.5069
+0.0132 (2.67%)
Sep 10, 2026, 11:29 AM EDT - Market open
Impact BioMedical Employees
Impact BioMedical had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$17,500
Profits / Employee
$395,500
Market Cap
54.65M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2 | 0 | - |
| Dec 31, 2024 | 2 | 1 | 100.00% |
| Dec 31, 2023 | 1 | -1 | -50.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Xilio Therapeutics | 76 |
| Seres Therapeutics | 66 |
| Elicio Therapeutics | 33 |
| eXoZymes | 32 |
| ImageneBio | 18 |
| Instil Bio | 17 |
| MiNK Therapeutics | 15 |
| Apollomics | 14 |
IBO News
- 4 weeks ago - Impact BioMedical Quarterly report: Q2 2026 - Filings
- 4 months ago - Impact BioMedical Quarterly report: Q1 2026 - Filings
- 5 months ago - Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans - GlobeNewsWire
- 6 months ago - Impact BioMedical Annual report: Q4 2025 - Filings
- 6 months ago - Why Is Impact BioMedical Stock (IBO) Up Today? - TipRanks
- 10 months ago - Impact BioMedical Quarterly report: Q3 2025 - Filings
- 11 months ago - Impact BioMedical Proxy statement: Proxy Filing - Filings
- 1 year ago - Impact BioMedical announces 3F U.S. patent issue - TheFly